Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: drdan who wrote (1234)	6/18/1998 2:33:00 PM
From: Hyrulean King	Respond to of 5402

Drdan - agreed! (eom)

To: drdan who wrote (1234)	6/18/1998 2:50:00 PM
From: RocketMan	Read Replies (2) \| Respond to of 5402

drdan, I agree 100%. SGNC is NOT a short term play, and there is a great deal of DD to do before we can feel totally comfortable. The Batelle contract only says that the technology is sufficiently promising for a national laboratory to invest in it. And that is only for initial animal trials, I assume (I am not a medical person). So although I am happy with the contract announcement, I also realize this has a long way to go. The last thing we want is a quick runup in the price, with the attendant scrutiny, naysayers, etc. I do believe this company will rise on its own merits, which is why I am invested in it. This company needs NO HYPE!